Results 131 to 140 of about 47,128 (346)

Trends in cancer mortality in Mexico, 1970-1999 [PDF]

open access: yes, 2017
Background: Few data on cancer mortality have been published for Mexico over the last few decades. It is therefore of interest to conduct a systematic and updated analysis of cancer mortality in this country. Patients and methods: Age-standardised (world
Bosetti, C.   +6 more
core  

Do Surveillance Tests for Relapse Improve Survival After Chemotherapy for Paediatric Acute Leukaemia? A Systematic Review

open access: yesPediatric Blood &Cancer, EarlyView.
Abstract Acute leukaemias are the commonest cancers in children and young people (CYP). Off‐treatment surveillance is assumed to improve relapse detection, but whether this affects subsequent survival and quality of life is unclear. This systematic review searched 13 databases and two trial registries in December 2022.
Connor Evans   +8 more
wiley   +1 more source

Spermatocytic tumor with extensive lymphovascular invasion in a young male

open access: yesUrology Case Reports
Spermatocytic tumors are rare testicular cancers, accounting for less than 1 % of all testicular neoplasms, usually affecting older men. This report details a 35-year-old male with a spermatocytic tumor featuring extensive lymphovascular invasion.
Payal Arvind Chawhan   +2 more
doaj   +1 more source

Testicular Metastasis of Prostate Cancer: A Case Report

open access: yesCase Reports in Oncology, 2014
The incidence of secondary neoplasms of the testis during autopsies is approximately 2.5%. Although most secondary testicular metastases are due to prostate cancer, only a few patients with prostate cancer have clinically manifested testicular metastasis.
Ayumu Kusaka   +8 more
doaj   +1 more source

Prenatal Evaluation of Scrotal Masses: A Systematic Literature Review

open access: yesPrenatal Diagnosis, EarlyView.
ABSTRACT Evaluation of fetal genitalia is often neglected after determining fetal sex, yet the identification of a scrotal mass may suggest significant underlying conditions requiring specific management. We conducted a systematic literature review, following PRISMA guidelines and registered with PROSPERO (CRD42024559035), on the five most common ...
Federica Romanzi   +12 more
wiley   +1 more source

Diagnostic and therapeutic approaches of para‐testicular SCRMS in an adolescent patient: A case report

open access: yesUroPrecision, EarlyView.
Abstract Background Para‐testicular rhabdomyosarcoma (RMS) is a rare and aggressive malignancy primarily affecting children and adolescents, with peak incidence between ages 2 and 5 years. Of the histological variants of RMS, the spindle cell type of RMS is particularly uncommon, accounting for approximately 5% of cases.
Kholoud Alabassi   +5 more
wiley   +1 more source

Clinical and pathological findings in giraffes (Giraffa camelopardalis) with arterial thrombotic disease

open access: yesVeterinary Record Case Reports, EarlyView.
Abstract Two adult female giraffes (Giraffa camelopardalis) from separate facilities were diagnosed with arterial thrombotic disease. The first giraffe presented with acute severe unilateral hindlimb paralysis. Infrared thermography revealed a marked temperature decrease compared to the contralateral limb starting from the mid‐thigh region, indicative ...
Pierre Huberdeau   +7 more
wiley   +1 more source

Is the Incidence of Early‐Onset Adenocarcinomas in Aotearoa New Zealand Increasing?

open access: yesAsia-Pacific Journal of Clinical Oncology, EarlyView.
There is a rising incidence of early‐onset adenocarcinomas in Aotearoa New Zealand which is site‐specific. This includes breast, colorectal, uterine, and prostate adenocarcinomas in the total population and colorectal, uterine, and lung adenocarcinomas in the Māori population.
Raymond Phang   +5 more
wiley   +1 more source

Primary testicular non-Hodgkin's lymphoma: a review article

open access: yesSão Paulo Medical Journal
Primary testicular non-Hodgkin's lymphoma was first described as a clinical entity in 1866. It is a rare disease and accounts for 1% of all non-Hodgkin's lymphoma, 2% of all extranodal lymphomas and 5% of all testicular neoplasms.
Komal Bhatia   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy